comicbooks.com Join Free
Oracle: The Cure #3 cover
Cover: Guillem March

Oracle: The Cure #3

Jul 2009 · DC · 2.99 USD
☆ Be the first to review + Add to your collection — Join free
“A Matter of Anti-Life or Death!”

In "A Matter of Anti-Life or Death!", Oracle races to stop the Calculator’s deadly scheme before he can eliminate more of her allies, using her sharp mind to outmaneuver him at every turn. With Wendy finally waking from her coma—though still paralyzed—Oracle must confront the aftermath of the attack and the cost of victory, all while facing the lingering threat of the Calculator’s twisted agenda. Written by Kevin VanHook and illustrated by Julian Lopez, Fernando Pasarin, and Norm Rapmund, with inks by Bit and colors by Hi-Fi, the issue’s cover by Guillem March captures the tension of a moment that could change everything.

writer Kevin VanHook · artist Julian Lopez · artist, inker Fernando Pasarin · inker Norm Rapmund · inker Bit · colorist Hi-Fi · letterer Steve Wands · cover Guillem March

ComicBooks.com Value

Our Model is In Beta
Raw (NM) $5
CGC 9.8 · 2 in census $56*
* estimate — limited direct-sales data at this grade
Our model’s value — refined as new sales data arrives · CGC census counts shown where available

This exact issue on

Raw — NM $2.25–$5.35 4 listings
Raw — VF/NM $3.53–$8.5 3 listings
Raw — VF $2.13–$9.4 2 listings
Raw — FN $7.1 1 listing
Raw / ungraded $1.81–$8.49 3 listings
Verified matches for Oracle: The Cure #3 · eBay asking prices, seen 6 days ago

More listings for this title

Sell my copy

Have this issue — or a whole collection? Get a fair offer from us, skip the marketplace fees and the hassle.

We Buy Collections ▸
Fast, fair offers · we handle grading & shipping

Full credits

artist, inker Fernando Pasarin
inker Bit
colorist Hi-Fi
letterer Steve Wands
cover pencils, inks Guillem March

Reprints

Reprinted in Batman Monster Edition #4 (2010), Oracle: The Cure #[nn] (2010), Batman: Battle for the Cowl - The Complete Collection #[nn] (2025)

Reviews

Reader reviews

No reader reviews yet.